首页> 外文期刊>BMC Pulmonary Medicine >The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome
【24h】

The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome

机译:急性呼吸窘迫综合征风险患者血清和支气管肺泡灌洗液炎症细胞因子的临床意义

获取原文
           

摘要

Background The predictive role of many cytokines has not been well defined in Acute Respiratory Distress Syndrome (ARDS). Methods We measured prospectively IL-4, IL-6, IL-6 receptor, IL-8, and IL-10, in the serum and bronchoalveolar lavage fluid (BALF) in 59 patients who were admitted to ICU in order to identify predictive factors for the course and outcome of ARDS. The patients were divided into three groups: those fulfilling the criteria for ARDS (n = 20, group A), those at risk for ARDS and developed ARDS within 48 hours (n = 12, group B), and those at risk for ARDS but never developed ARDS (n = 27, group C). Results An excellent negative predictive value for ARDS development was found for IL-6 in BALF and serum (100% and 95%, respectively). IL-8 in BALF and IL-8 and IL-10 serum levels were higher in non-survivors in all studied groups, and were associated with a high negative predictive value. A significant correlation was found between IL-8 and APACHE score (r = 0.60, p Conclusions BALF and serum levels of the studied cytokines on admission may provide valuable information for ARDS development in patients at risk, and outcome in patients either in ARDS or in at risk for ARDS.
机译:背景技术在急性呼吸窘迫综合征(ARDS)中,许多细胞因子的预测作用尚未明确。方法我们对59例接受ICU的患者的血清和支气管肺泡灌洗液(BALF)中的IL-4,IL-6,IL-6受体,IL-8和IL-10进行了前瞻性测量,以找出预测因素关于ARDS的过程和结果。将患者分为三组:符合ARDS标准的患者(n = 20,A组),有ARDS风险并在48小时内发展为ARDS的患者(n = 12,B组),以及有ARDS风险但从未开发过ARDS(n = 27,C组)。结果发现BALF和血清中IL-6对ARDS的发展具有极好的阴性预测值(分别为100%和95%)。在所有研究组中,非存活者的BALF中的IL-8和IL-8和IL-10血清水平较高,并且与较高的阴性预测值相关。 IL-8与APACHE评分之间存在显着相关性(r = 0.60,p)结论入院时BALF和所研究细胞因子的血清水平可能为有风险的患者发展ARDS以及在ARDS或结直肠癌患者的结局提供有价值的信息。有ARDS的危险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号